The US Food and Drug Administration issued a proposed rule titled, “Nonprescription Drug Product with an Additional Condition for Nonprescription Use,” which the agency says is intended to broaden the range of marketed nonprescription drugs available to consumers, empowering them to self-treat certain common conditions and improving public health. Nonprescription drug products are important for the treatment of many conditions and diseases, although at present most nonprescription d...